December 11, 2024

Does acalabrutinib fit into frontline therapy for patients with mantle cell lymphoma? (Study EA4181)

December 4, 2024

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

November 26, 2024

WATCH: David Schiff discusses the striking survival improvement for patients with low-grade brain tumors found in study E3F05

October 30, 2024

ECOG-ACRIN and Caris partner to learn more from the TAILORx trial

October 30, 2024

Using the geriatric assessment to actualize goal-concordant care (with EA2186/GIANT study chair Dr. Efrat Dotan)

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

October 29, 2024

WATCH: Breast Cancer Research Foundation hosts Dr. Joseph Sparano and Amanda Quick of The Pink Agenda to discuss metastatic breast cancer

October 25, 2024

ECOG-ACRIN Lymphoma Committee co-chair Andrew Evens comments on the results of the SWOG study S1826, Nivolumab-AVD in Advanced-Stage Classic Hodgkin Lymphoma

October 25, 2024

ECOG-ACRIN and Caris to analyze samples from TAILORx (requires free registration)

ECOG-ACRIN Cancer Research Group